These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach. Gulba DC Thromb Haemost; 1999 Aug; 82(2):953-61. PubMed ID: 10605809 [No Abstract] [Full Text] [Related]
13. [Antithrombotics in pre-hospital phase of acute coronary syndromes]. Collet JP; Dumaine R; Ecollan P; Beygui F; Choussat R; Boon G; Payot L; Montalescot G Arch Mal Coeur Vaiss; 2005 Nov; 98(11):1118-22. PubMed ID: 16379108 [TBL] [Abstract][Full Text] [Related]
17. Aspirin augmentation of the efficacy of thrombolysis. O'Donnell CJ; Jonas MA; Hennekens CH Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015 [No Abstract] [Full Text] [Related]
18. Warfarin, aspirin, or both after myocardial infarction. Amit G; Ilia R; Zahger D N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530435 [No Abstract] [Full Text] [Related]
19. Challenging the conclusions drawn in "Thrombolysis for acute myocardial infarction: drug review". Howlett M MedGenMed; 2002 Feb; 4(1):6; author reply 7. PubMed ID: 11965208 [No Abstract] [Full Text] [Related]
20. [Health and cardiovascular diseases in women]. Beiras AC Rev Esp Cardiol; 1994; 47 Suppl 3():1-5. PubMed ID: 7816973 [No Abstract] [Full Text] [Related] [Next] [New Search]